| | PATHWAY: hsa00240 | |
Entry |
|
Name |
Pyrimidine metabolism - Homo sapiens (human) |
Class |
Metabolism; Nucleotide metabolism
|
Pathway map |
|
Module |
hsa_M00046 | Pyrimidine degradation, uracil => beta-alanine, thymine => 3-aminoisobutanoate [PATH:hsa00240] |
hsa_M00053 | Deoxyribonucleotide biosynthesis, ADP/GDP/CDP/UDP => dATP/dGTP/dCTP/dUTP [PATH:hsa00240] |
|
Drug |
D00584 | Fluorouracil (JP18/USP/INN) |
D00749 | Leflunomide (JAN/USP/INN) |
D01064 | Raltitrexed (JAN/USAN/INN) |
D01155 | Gemcitabine hydrochloride (JAN/USP) |
D01223 | Capecitabine (JAN/USP/INN) |
D01244 | Tegafur (JP18/USAN/INN) |
D01309 | Doxifluridine (JP18/INN) |
D01370 | Cladribine (JAN/USP/INN) |
D01907 | Fludarabine phosphate (JAN/USP) |
D03154 | Brequinar sodium (USAN) |
D03546 | Clofarabine (JAN/USAN/INN) |
D04245 | Forodesine hydrochloride (JAN/USAN) |
D04964 | Metesind glucuronate (USAN) |
D07974 | Fluorouracil sodium salt |
D10222 | Gemcitabine elaidate (USAN/INN) |
D10432 | Ulodesine succinate (USAN) |
D11447 | Arfolitixorin (USAN/INN) |
D12373 | Quemliclustat (USAN/INN) |
D12387 | Fosgemcitabine palabenamide (USAN/INN) |
D12388 | Fosifloxuridine nafalbenamide |
D12466 | Doxribtimine (USAN/INN) |
D12528 | Arfolitixorin sulfate (JAN) |
|
Other DBs |
|
Organism |
Homo sapiens (human) [GN: hsa]
|
Gene |
956 | ENTPD3; ectonucleoside triphosphate diphosphohydrolase 3 [KO:K01510] [EC:3.6.1.5] |
953 | ENTPD1; ectonucleoside triphosphate diphosphohydrolase 1 [KO:K01510] [EC:3.6.1.5] |
9583 | ENTPD4; ectonucleoside triphosphate diphosphohydrolase 4 [KO:K12305] [EC:3.6.1.6] |
957 | ENTPD5; ectonucleoside triphosphate diphosphohydrolase 5 (inactive) [KO:K01511] [EC:3.6.1.6] |
955 | ENTPD6; ectonucleoside triphosphate diphosphohydrolase 6 [KO:K01511] [EC:3.6.1.6] |
8623 | ASMTL; acetylserotonin O-methyltransferase like [KO:K25435] [EC:3.6.1.- 2.1.1.-] |
50484 | RRM2B; ribonucleotide reductase regulatory TP53 inducible subunit M2B [KO:K10808] [EC:1.17.4.1] |
|
Compound |
C00119 | 5-Phospho-alpha-D-ribose 1-diphosphate |
C00438 | N-Carbamoyl-L-aspartate |
C00672 | 2-Deoxy-D-ribose 1-phosphate |
C01168 | Pseudouridine 5'-phosphate |
C01205 | (R)-3-Amino-2-methylpropanoate |
C03997 | 5-Hydroxymethyldeoxycytidylate |
C06198 | P1,P4-Bis(5'-uridyl) tetraphosphate |
C11038 | 2'-Deoxy-5-hydroxymethylcytidine-5'-diphosphate |
C11039 | 2'-Deoxy-5-hydroxymethylcytidine-5'-triphosphate |
C15607 | 3-Oxo-3-ureidopropanoate |
C20231 | (Z)-3-Ureidoacrylate peracid |
C20249 | (Z)-3-Peroxyaminoacrylate |
C20846 | 3-Oxo-3-ureidoisobutyrate |
C21029 | (R)-3-Ureidoisobutyrate |
|
Related pathway |
hsa00250 | Alanine, aspartate and glutamate metabolism |
hsa00280 | Valine, leucine and isoleucine degradation |
|
KO pathway |
|
|
|
|